Navigation Links
Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies

Leading biotech companies like Pfizer are increasingly interested in acquisition of smaller biotech companies whose products are in the early phase 2 clinical trials.// “Smaller companies are more willing to consider acquisition then they used to be,” notes Roger Longman, Managing Partner at Healthcare business information specialist for Windhover information. The possibilities of going public after acquisition is very high for these small companies and is one of these reasons these companies are considering a big pharma buy out.

This year lot of companies have choose acquisition – San Diego based Idun Pharmaceutical and Syrix Pharmaceuticals (Pfizer), TransForm Pharmaceuticals and NeoGenesis, both located outside Botson (Johnson & Johnson and Scherring-Plough).

With most late stage product candidates are not interested by the alliancing partner as late stage alliance are very expensive, and does not give an optimal ratio between price and probability of success. Thus at Pfizer “We tend to go earlier because we have good productive tools, to be able to get to a decision point as quickly as possible”, says Martin Mackay, Sr. Vice President, Pfizer. This was the reasons behind acquisition of Idun Pharmaceuticals, in the development of Caspase modulators, which are proteins involved in apoptosis but that remains unproven as a drug target. Pfizer says that it can quickly develop the potential for Caspase targeting compounds, which Idun is developing for broad range of disorders including liver diseases, cancer and inflammation.

Given the uncertainties around the availability of future financing and overall costs of drug development, “Conversation for potentially important products often get to the obvious point of considering an acquisition” summarizes Antony Envin of Venture Capital firm, Venrack Associates.

Source: Nature Biotechnoloy.
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Antidepressant Medication Leading To Suicidal Thoughts
3. Alcohol And Drug Abuse (Cannabis) Leading Causes For Road Traffic Accidents
4. Down’s Syndrome Is The Leading Birth Defect In the U
5. Exposure to Grating, Noise, Music Can Cause Tumors Leading To Deafness
6. Bottleneck: High on Spirits Can Cause A Dispirited Liver, Leading To Cirrhosis!
7. Foetuses Cant Feel Pain Says A Leading Psychologist
8. Oxygen-Induced Damage A Leading Cause For Parkinson’s Diseas
9. Cardiogenic Shock is the Leading Cause of Death for Heart Attack Patients
10. A Correlative Study On The Link Between Education And The Leading Causes Of Preventable Death
11. Spurious Drugs is a Leading Cause of Casualties Among Drug Users
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... ... Textile Exchange is excited to announce the release of the second ... is an important opportunity for interested parties to give input into the standard, and ... The RWS is intended to be a global benchmark for animal welfare and land ...
(Date:5/5/2016)... ... May 05, 2016 , ... Einstein Medical is proud ... cover the latest news and commentary at the 2016 ASCRS/ASOA Symposium and Congress, which ... American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrations ...
(Date:5/5/2016)... ... May 05, 2016 , ... TLC Laser Eye Centers announced today that ... eye center will now be called “Gordon Schanzlin New Vision Institute, a TLC Laser ... the full-service facility to ensure that patients continue to receive the highest quality of ...
(Date:5/5/2016)... ... May 05, 2016 , ... Spring Fertility , ... IVF and with egg freezing, today announced the grand opening of its first ... fertility care, Spring Fertility offers both fertility preservation (egg, sperm, embryo, and testicular ...
(Date:5/5/2016)... Francisco, CA (PRWEB) , ... ... ... intensive lectures and hands-on exercises, the Wharton Seminars for Business Journalists ... a better understanding of key business and economic issues.  This one-day program ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... ZIONA, Israel , May 4, ... TASE: BVXV) announced today that BiondVax,s CEO, Dr. Ron ... conference in New York City . ... at 10:30am at Pioneers 2016, a conference presented by ... York Palace Hotel. The BiondVax presentation that Dr. ...
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Actinic Keratosis Market ... to their offering.       (Logo: ... Keratosis Market and Competitive Landscape Highlights 2016, ... products, Actinic Keratosis epidemiology, Actinic Keratosis market ...
Breaking Medicine Technology: